The following is a summary of “Mitochondrial Metabolism Gene ECH1 Was Identified as a Novel Biomarker for Diabetic ...

XORTX Therapeutics Inc. ("XORTX" or the “Company”) (NASDAQ: XRTX | TSXV: XRTX | Frankfurt: ANU), a late stage clinical ...

The global dialysis device and concentrates market is poised for significant expansion, forecasted to grow from USD 23,690.3 million in 2025 to USD 79,224.7 million by 2035, representing a steady CAGR ...

XORTX Therapeutics Inc. ("XORTX" or the "Company") (NASDAQ: XRTX | TSXV: XRTX | Frankfurt: ANU), a late stage clinical pharmaceutical company focused ...

Mesoblast Limited’s MESO share price has surged by 5.14%, which has investors questioning if this is right time to sell.

However, foamy urine can be a symptom of serious health conditions that require immediate medical attention.  You should see ...

Abstract: Diabetes and its complications, especially Diabetic Retinopathy (DR) and Diabetic Nephropathy (DN) is a big challenge to the global healthcare system and needs accurate predictive models to ...

XORTX Therapeutics Inc ( ($TSE:XRTX) ) has issued an announcement. XORTX Therapeutics Inc. has received a notification from the Nasdaq Stock ...

Table 1. Diabetic Nephropathy Stages: Cutoff Values of Urine Albumin for Diagnosis and Main Clinical Characteristics Stages Albuminuria cutoff values (ref. 14) Clinical characteristics (ref. no.) ...

When the stock market is highly volatile, many investors flock to assets that offer stability but dismal growth prospects.

This listicle highlights recent technological and analytical advances propelling metabolomics forward and explores how these ...

Diabetic kidney disease is chronic kidney disease that occurs as a complication of diabetes. Learn about its signs and ...